Overview

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma

Status:
Unknown status

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to determine the tolerance and overall survival in patients with stage ⅣAB NPC treated with neoadjuvant chemotherapy and concurrent chemoradiation. Secondary objectives of the study are to evaluate the distant metastases free survival, and disease-free survival of patients with stage ⅣAB treated with this regimen

Phase:

Phase 2

Details

Lead Sponsor:

Fudan University

Treatments:

Cisplatin
Docetaxel
Fluorouracil